Advances in anticancer radiopharmaceuticals.
This review highlights recent progress in the development of anticancer radiopharmaceuticals. Molecularly targeted radiotherapy refers to the selective delivery of radionuclides that emit charged particles, such as α particles, β or Auger electrons, to cancer cells via a targeting vector. The discov...
Hlavní autoři: | Jackson, MR, Falzone, N, Vallis, K |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2013
|
Podobné jednotky
-
Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical
Autor: Cornelissen, B, a další
Vydáno: (2012) -
Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.
Autor: Cornelissen, B, a další
Vydáno: (2012) -
Targeted radionuclide therapy: new advances for improvement of patient management and response
Autor: Malcolm, J, a další
Vydáno: (2019) -
Radiopharmaceuticals for imaging and therapy.
Autor: Faulkner, S, a další
Vydáno: (2011) -
Regulation of Radiopharmaceutical Products
Autor: V. V. Kosenko, a další
Vydáno: (2022-12-01)